Anzeige
+++Die FED hat die Zinsen erhöht.: Gold explodiert. Was kommt jetzt?+++
Portfolio Tracker
Alle Depots an einem Ort. Dein Gesamtvermögen immer im Blick, tiefgründige Renditeanalysen und Dividendenplaner.
Anzeige
EQS-News

Organizations Unite to Defend Texas Dementia Research Initiative 18.09.2026, 17:16 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: American Heart Association / Key word(s): Healthcare
Organizations Unite to Defend Texas Dementia Research Initiative

18.09.2026 / 17:16 CET/CEST
The issuer is solely responsible for the content of this announcement.


AUSTIN - September 18, 2026 (NEWMEDIAWIRE) - The Texas-headquartered American Heart Association, a relentless force changing the future of health for everyone, everywhere, and the Alzheimer’s Association, the leading voluntary health organization dedicated to Alzheimer's care, support and research, have filed an amicus brief supporting the Dementia Prevention and Research Institute of Texas (DPRIT), a voter-approved initiative to advance research on Alzheimer’s disease and related dementias. The filing comes as litigation has delayed implementation of the groundbreaking initiative approved through Proposition 14 in November 2025. The measure passed with nearly 70% of the vote.

AHA_LOGO-RGB_rk_LG.jpg

The brief requests the Court of Appeals for the Fifteenth Judicial District affirm the trial court’s dismissal of this case in its entirety based on the following arguments:

  • Proposition 14 builds on a proven Texas model for medical research.
  • DPRIT will advance research of critical importance to the health of Texans.
  • Continued delay in implementing DPRIT is contrary to the public interest.

This investment is important because nearly 460,000 Texans age 65 and older are living with Alzheimer’s disease, affecting families, caregivers and communities across the state. DPRIT is also an investment in the Texans who don't have cognitive impairment today. Research is what moves prevention, risk reduction and early detection from promising to proven - and what determines how the next generation ages.

“Texas voters sent a clear message when they approved Proposition 14: families facing Alzheimer’s and other dementias cannot afford to wait. Every day of delay slows discovery, stalls the recruitment of top researchers to the state and pushes improved treatments and diagnosis further out of reach,” said Joanne Pike, DrPH, president and CEO of the Alzheimer’s Association. “DPRIT is an investment in what comes next: better prevention, earlier detection and a generation that grows older with more control over its brain health. We will keep working to see it succeed, because what it discovers will reach families far beyond Texas."

The American Heart Association advocated for the passage of Proposition 14 and supports DPRIT because evidence shows heart health and brain health are deeply interconnected. Many of the same risk factors that increase the likelihood of heart disease and stroke, including high blood pressure, tobacco use, physical inactivity and obesity, are also linked to premature cognitive decline and dementia.

The Alzheimer's Association supported the legislation that established DPRIT and led the voter education campaign that carried Proposition 14. That work rests on decades of engagement with state lawmakers and a grassroots network of advocates and community partners across Texas, and the Association is committed to seeing the voters' mandate fulfilled.

"Breakthroughs don't happen by accident - they happen when communities make a long-term commitment to science, innovation and the people whose lives depend on them,” said Nancy Brown, CEO of the American Heart Association. ”The fight against Alzheimer’s and dementia is one of the most urgent public health challenges of our time, and progress depends on our willingness to invest in science before families run out of options. That’s exactly the opportunity Texas voters embraced through Proposition 14.”

Voter-approved Proposition 14 provides $3 billion to DPRIT over 10 years, making it the largest state investment in brain health research in U.S. history.

In calling for a swift resolution of the legal challenges standing in the way of this life saving and life changing research, the Heart Association and Alzheimer’s Association and the many patients and families we represent remain committed to working with the Texas lieutenant governor, other state elected officials and research and public health institutions across the state to implement DPRIT and initiate this investment to accelerate progress in brain-health research.

Additional Resources:

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.orgFacebookX or by calling 1-800-AHA-USA1.

About the Alzheimer’s Association

The Alzheimer’s Association is a worldwide voluntary health organization dedicated to Alzheimer’s care, support and research. Our mission is to lead the way to end Alzheimer's and all other dementia - by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. Visit alz.org or call 800.272.3900.

For Media Inquiries - 214-706-1173

American Heart Association: Shelly.Hogan@heart.org

Alzheimer’s Association: 312.335.4078, Media@alz.org

For Public Inquiries: 1-800-AHA-USA1 (242-8721)

View the original release on www.newmediawire.com


News Source: American Heart Association


18.09.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: American Heart Association
United States
EQS News ID: 2401794

 
End of News EQS News Service

2401794  18.09.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer